Skip to main content
SpringerLink
Log in

Nano-sized Advanced Delivery Systems as Parenteral Formulation Strategies for Hydrophobic Anti-cancer Drugs

  • Chapter
Nanotechnology in Drug Delivery

Part of the book series: Biotechnology: Pharmaceutical Aspects ((PHARMASP,volume X))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham, S. A.; Waterhouse, D. N.; Mayer, L. D.; Cullis, P. R.; Madden, T. D.; Bally, M. B., The liposomal formulation of doxorubicin. Liposomes, Pt E, 2005; Vol. 391, pp 71–97.

    CAS  Google Scholar 

  • Adams, M. L.; Kwon, G. S., Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length. Journal of Controlled Release 2003, 87, (1–3), 23–32.

    CAS  PubMed  Google Scholar 

  • Adams, M. L.; Lavasanifar, A.; Kwon, G. S., Amphiphilic block copolymers for drug delivery. Journal of Pharmaceutical Sciences 2003, 92, (7), 1343–55.

    CAS  PubMed  Google Scholar 

  • Alakhov, V., Polymer-Based Nanomedicines for Oncology: From Preclinical Studies to the Clinical Proof of the Concept. In 4th International Nanomedicine and Drug Delivery Symposium, Omaha, Nebraska, US, 2006.

    Google Scholar 

  • Alakhov, V., Klinski, E., Li, S., Pietrzynski, G., Venne, A., Batrakova, E., Bronitch, T., and Kabanov, A., Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids and Surfaces B: Biointerfaces 1999, 16, 113–134.

    CAS  Google Scholar 

  • Aliabadi, H. M.; Mahmud, A.; Sharifabadi, A. D.; Lavasanifar, A., Micelles of methoxy poly(ethylene oxide)-b-poly(É›-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. Journal of Controlled Release 2005, 104, (2), 301–311.

    CAS  PubMed  Google Scholar 

  • Allen, C., Han, J., Yu, T., Maysinger, D., and Eisenberg, A., Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. Journal of Controlled Release 2000, 63, 275–286.

    CAS  PubMed  Google Scholar 

  • Allen, C., Maysinger, D., and Eisenberg, A., Nano-engineering block copolymer aggregates for drug delivery. Colloids and Surfaces B: Biointerfaces 1999, 16, 3–27.

    CAS  Google Scholar 

  • Allen, C.; Yu, Y.; Maysinger, D.; Eisenberg, A., Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjugate Chemistry 1998, 9, (5), 564–72.

    CAS  PubMed  Google Scholar 

  • Allen, T. M., Long-Circulating (Sterically Stabilized) Liposomes for Targeted Drug-Delivery. Trends in Pharmacological Sciences 1994, 15, (7), 215–220.

    CAS  PubMed  Google Scholar 

  • Allen, T. M.; Chonn, A., Large Unilamellar Liposomes with Low Uptake into the Reticuloendothelial System. Febs Letters 1987, 223, (1), 42–46.

    CAS  PubMed  Google Scholar 

  • Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yauyoung, A., Liposomes Containing Synthetic Lipid Derivatives of Poly(Ethylene Glycol) Show Prolonged Circulation Half-Lives Invivo. Biochimica Et Biophysica Acta 1991, 1066, (1), 29–36.

    CAS  PubMed  Google Scholar 

  • Allen, T. M.; Martin, F. J., Advantages of liposomal delivery systems for anthracyclines. Seminars in Oncology 2004, 31, (6), 5–15.

    CAS  PubMed  Google Scholar 

  • Allen, T. M.; Stuart, D. D., Liposome Pharmacokinetics. Liposomes - Rational Design, Janoff, A. S., Ed. Marcel Dekker, Inc.: New York, 1999; pp 63–87.

    Google Scholar 

  • Baban, D. F.; Seymour, L. W., Control of tumour vascular permeability. Advanced Drug Delivery Reviews 1998, 34, (1), 109–119.

    CAS  PubMed  Google Scholar 

  • Bader, H.; Ringsdorf, H.; Schmidt, B., Watersoluble Polymers in Medicine. Die Angewandte Makromolekulare Chemie 1984, 123/124, 457–485.

    CAS  Google Scholar 

  • Bangham, A. D.; Standish, M. M.; Watkins, J. C., Diffusion of Univalent Ions across Lamellae of Swollen Phospholipids. Journal of Molecular Biology 1965, 13, (1), 238–252.

    CAS  PubMed  Google Scholar 

  • Bartsch, W.; Sponer, G.; Dietmann, K.; Fuchs, G., Acute toxicity of various solvents in the mouse and rat. LD50 of ethanol, diethylacetamide, dimethylformamide, dimethylsulfoxide, glycerine, N-methylpyrrolidone, polyethylene glycol 400, 1,2-propanediol and Tween 20. Arzneimittelforschung 1976, 26, (8), 1581–3.

    CAS  PubMed  Google Scholar 

  • Batrakova, E. V., Li, S., Li, Y., Alakhov, V.Y., Elmquist, W.F., and Kabanov, A.V., Distribution kinetics of a micelle-forming block copolymer Pluronic P85. Journal of Controlled Release 2004, 100, 389–397.

    CAS  PubMed  Google Scholar 

  • Batrakova, E. V., Li, S., Miller, D.W., and Kabanov, A.V., Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and caco-2 cell monolayers. Pharmaceutical Research 1999, 16, (9), 1366–1372.

    CAS  PubMed  Google Scholar 

  • Benahmed, A.; Ranger, M.; Leroux, J. C., Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(D,L-lactide). Pharmaceutical Research 2001, 18, (3), 323–8.

    CAS  PubMed  Google Scholar 

  • Bhatt, R.; De Vries, P.; Tulinsky, J.; Bellamy, G.; Baker, B.; Singer, J. W.; Klein, P., Synthesis and in vivo antitumor activity of poly(L-glutamic acid) conjugates of 20(S)-camptothecin. Journal of Medicinal Chemistry 2003, 46, (1), 190–193.

    CAS  PubMed  Google Scholar 

  • Brazeau, G. A.; Cooper, B.; Svetic, K. A.; Smith, C. L.; Gupta, P., Current perspectives on pain upon injection of drugs. Journal of Pharmaceutical Sciences 1998, 87, (6), 667–77.

    CAS  PubMed  Google Scholar 

  • Cabanes, A.; Briggs, K. E.; Gokhale, P. C.; Treat, J. A.; Rahman, A., Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. International Journal of Oncology 1998, 12, (5), 1035–1040.

    CAS  PubMed  Google Scholar 

  • Carmona-Ribeiro, A. M., Lipid bilayer fragments and disks in drug delivery. Current Medicinal Chemistry 2006, 13, (12), 1359–1370.

    CAS  PubMed  Google Scholar 

  • Chen, J.; Ping, Q. N.; Guo, J. X.; Chu, X. Z.; Song, M. M., Effect of phospholipid composition on characterization of liposomes containing 9-nitrocamptothecin. Drug Development and Industrial Pharmacy 2006, 32, (6), 719–726.

    CAS  PubMed  Google Scholar 

  • Cho, Y. W.; Lee, J.; Lee, S. C.; Huh, K. M.; Park, K., Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. Journal of Controlled Release 2004, 97, (2), 249–57.

    CAS  PubMed  Google Scholar 

  • Choucair, A.; Eisenberg, A., Control of amphiphilic block copolymer morphologies using solution conditions. The European Physical Journal E 2003, 10, 37–44.

    CAS  Google Scholar 

  • Chow, D. S. L.; Gong, L.; Wolfe, M. D.; Giovanella, B. C., Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin. In Camptothecins: Unfolding Their Anticaner Potential, 2000; Vol. 922, pp 164–174.

    CAS  Google Scholar 

  • Chung, T. W.; Cho, K. Y.; Lee, H.-C.; Nah, J. W.; Yeo, J. H.; Akaike, T.; Cho, C. S., Novel micelle-forming block copolymer composed of poly (É›- caprolactone) and poly(vinyl pyrrolidone). Polymer 2004, 45, (5), 1591–1597.

    CAS  Google Scholar 

  • Croy, S. R.; Kwon, G. S., The effects of Pluronic block copolymers on the aggregation state of nystatin. Journal of Controlled Release 2004, 95, (2), 161–171.

    CAS  PubMed  Google Scholar 

  • Danhauser-Riedl, S.; Hausmann, E.; Schick, H.-D.; Bender, R.; Dietzfelbinger, H.; Rastetter, J.; Hanauske, A.-R., Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Investigational New Drugs 1993, 11, (2–3), 187–195.

    CAS  PubMed  Google Scholar 

  • Danson, S.; Ferry, D.; Alakhov, V.; Margison, J.; Kerr, D.; Jowle, D.; Brampton, M.; Halbert, G.; Ranson, M., Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. British Journal of Cancer 2004, 90, (11), 2085–2091.

    CAS  PubMed  Google Scholar 

  • Defrise-Quertain, F.; Chatelain, P.; Delmelle, M.; Ruysschaert, J.-M., Model Studies for Drug Entrapment and Liposome Stability. In Liposome Technology, Gregoriadis, G., Ed. CRC Press, Inc: Boca Raton, 1984; Vol. II, pp 1–18.

    Google Scholar 

  • Discher, D. E.; Eisenberg, A., Polymer vesicles. Science 2002, 297, (5583), 967–73.

    CAS  PubMed  Google Scholar 

  • Drummond, D. C.; Meyer, O.; Hong, K. L.; Kirpotin, D. B.; Papahadjopoulos, D., Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacological Reviews 1999, 51, (4), 691–743.

    CAS  PubMed  Google Scholar 

  • Duncan, R., Polymer conjugates as anticancer nanomedicines. Nature Reviews Cancer 2006, 6, (9), 688–701.

    CAS  PubMed  Google Scholar 

  • Duncan, R., The dawning era of polymer therapeutics. Nature Reviews Drug Discovery 2003, 2, (5), 347–360.

    CAS  PubMed  Google Scholar 

  • Duncan, R.; Cable, H. C.; Lloyd, J. B.; Rejmanova, P.; Kopecek, J., Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. Bioscience Reports 1982, 2, (12), 1041–6.

    CAS  PubMed  Google Scholar 

  • Duncan, R.; Gac-Breton, S.; Keane, R.; Musila, R.; Sat, Y. N.; Satchi, R.; Searle, F., Polymer-drug conjugates, PDEPT and PELT: Basic principles for design and transfer from the laboratory to clinic. Journal of Controlled Release 2001, 74, (1–3), 135–146.

    CAS  PubMed  Google Scholar 

  • Duncan, R.; Pratten, M. K.; Cable, H. C.; Ringsdorf, H.; Lloyd, J. B., Effect of molecular size of 125I-labelled poly(vinylpyrrolidone) on its pinocytosis by rat visceral yolk sacs and rat peritoneal macrophages. Biochemical Journal 1981, 196, (1), 49–55.

    CAS  PubMed  Google Scholar 

  • Duncan, R.; Ringsdorf, H.; Satchi-Fainaro, R., Polymer therapeutics: Polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities. Advances in Polymer Science 2006, 192, (1), 1–8.

    CAS  Google Scholar 

  • Ehlrich, P., Collected Studies on Immunity. J. Wiley & Sons: New York, 1906; p 442.

    Google Scholar 

  • Emerson, D. L.; Bendele, R.; Brown, E.; Chiang, S. M.; Desjardins, J. P.; Dihel, L. C.; Gill, S. C.; Hamilton, M.; LeRay, J. D.; Moon-McDermott, L.; Moynihan, K.; Richardson, F. C.; Tomkinson, B.; Luzzio, M. J.; Baccanari, D., Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: A low-clearance liposomal formulation of lurtotecan. Clinical Cancer Research 2000, 6, (7), 2903–2912.

    CAS  PubMed  Google Scholar 

  • Forssen, E. A., The design and development of DaunoXome(R) for solid tumor targeting in vivo. Advanced Drug Delivery Reviews 1997, 24, (2–3), 133–150.

    CAS  Google Scholar 

  • Fournier, E.; Dufresne, M. H.; Smith, D. C.; Ranger, M.; Leroux, J. C., A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharmaceutical Research 2004, 21, (6), 962–968.

    CAS  PubMed  Google Scholar 

  • Frank, D. W.; Gray, J. E.; Weaver, R. N., Cyclodextrin nephrosis in the rat. American Journal of Pathology 1976, 83, (2), 367–82.

    CAS  PubMed  Google Scholar 

  • Fried, M. W.; Shiffman, M. L.; Reddy, K. R.; Smith, C.; Marinos, G.; Goncales Jr., F. L.; Haussinger, D.; Diago, M.; Carosi, G.; Dhumeaux, D.; Craxi, A.; Lin, A.; Hoffman, J.; Yu, J., Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine 2002, 347, (13), 975–982.

    CAS  PubMed  Google Scholar 

  • Fu, R. C.; Lidgate, D. M.; Whatley, J. L.; McCullough, T., The biocompatibility of parenteral vehicles–in vitro/in vivo screening comparison and the effect of excipients on hemolysis. Journal of Parenteral Science and Technology 1987, 41, (5), 164–8.

    CAS  PubMed  Google Scholar 

  • Fukushima, S., Machida, M., Akutsu, T., Shimizu, K., Tanaka, S., Okamoto, K., Mashiba, H., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Roles of adriamycin and adriamycin dimer in antitumor activity of the polymeric micelle carrier system. Colloids and Surfaces B: Biointerfaces 1999, 16, 227–236.

    CAS  Google Scholar 

  • Gabizon, A. A., Applications of Liposomal Drug Delivery Systems to Cancer Therapy. In Nanotechnology for Cancer Therapy, Amiji, M. M., Ed. CRC Press: Boca Raton, 2007; pp 595–611.

    Google Scholar 

  • Gabizon, A. A., Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy. Cancer Investigation 2001, 19, (4), 424–436.

    CAS  PubMed  Google Scholar 

  • Gabizon, A.; Papahadjopoulos, D., Liposome Formulations with Prolonged Circulation Time in Blood and Enhanced Uptake by Tumors. Proceedings of the National Academy of Sciences of the United States of America 1988, 85, (18), 6949–6953.

    CAS  PubMed  Google Scholar 

  • Gianni, L.; Kearns, C. M.; Giani, A.; Capri, G.; Vigano, L.; Locatelli, A.; Bonadonna, G.; Egorin, M. J., Nonlinear Pharmacokinetics and Metabolism of Paclitaxel and Its Pharmacokinetic/Pharmacodynamic Relationships in Humans. Journal of Clinical Oncology 1995, 13, (1), 180–190.

    CAS  PubMed  Google Scholar 

  • Graham, M. L., Pegaspargase: A review of clinical studies. Advanced Drug Delivery Reviews 2003, 55, (10), 1293–1302.

    CAS  PubMed  Google Scholar 

  • Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D., Effective drug delivery by PEGylated drug conjugates. Advanced Drug Delivery Reviews 2003, 55, (2), 217–50.

    CAS  PubMed  Google Scholar 

  • Greenwald, R. B.; Gilbert, C. W.; Pendri, A.; Conover, C. D.; Xia, J.; Martinez, A., Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness. Journal of Medicinal Chemistry 1996, 39, (2), 424–31.

    CAS  PubMed  Google Scholar 

  • Gregoriadis, G.; Ryman, B. E., Liposomes as Carriers of Enzymes or Drugs - New Approach to Treatment of Storage Diseases. Biochemical Journal 1971, 124, (5), 58P.

    CAS  PubMed  Google Scholar 

  • Guchelaar, H.-J.; Ten Napel, C. H. H.; De Vries, E. G. E.; Mulder, N. H., Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A review. Clinical Oncology 1994, 6, (1), 40–48.

    CAS  PubMed  Google Scholar 

  • Hamaguchi, T.; Matsumura, Y.; Suzuki, M.; Shimizu, K.; Goda, R.; Nakamura, I.; Nakatomi, I.; Yokoyama, M.; Kataoka, K.; Kakizoe, T., NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. British Journal of Cancer 2005, 92, (7), 1240–6.

    CAS  PubMed  Google Scholar 

  • Haran, G.; Cohen, R.; Bar, L. K.; Barenholz, Y., Transmembrane Ammonium-Sulfate Gradients in Liposomes Produce Efficient and Stable Entrapment of Amphipathic Weak Bases. Biochimica Et Biophysica Acta 1993, 1151, (2), 201–215.

    CAS  PubMed  Google Scholar 

  • Harris, J. M.; Chess, R. B., Effect of pegylation on pharmaceuticals. Nature Reviews Drug Discovery 2003, 2, (3), 214–21.

    CAS  PubMed  Google Scholar 

  • Hauswirth, A. W.; Simonitsch-Klupp, I.; Uffmann, M.; Koller, E.; Sperr, W. R.; Lechner, K.; Valent, P., Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: Report of five cases and review of the literature. Leukemia Research 2004, 28, (3), 249–257.

    CAS  PubMed  Google Scholar 

  • Hite, M.; Turner, S.; Federici, C., Part 1: Oral Delivery of Poorly Soluble Drugs. Pharmaceutical Manufacturing and Packing Sourcer 2003, Summer '03.

    Google Scholar 

  • Ho, D. H.; Brown, N. S.; Yen, A., Clinical pharmacology of polyethylene glycol-L-asparaginase. Drug Metabolism and Disposition 1986, 14, (3), 349–352.

    CAS  PubMed  Google Scholar 

  • Hofheinz, R. D.; Gnad-Vogt, S. U.; Beyer, U.; Hochhaus, A., Liposomal encapsulated anti-cancer drugs. Anti-Cancer Drugs 2005, 16, (7), 691–707.

    CAS  PubMed  Google Scholar 

  • Hope, M. J.; Bally, M. B.; Webb, G.; Cullis, P. R., Production of Large Unilamellar Vesicles by a Rapid Extrusion Procedure - Characterization of Size Distribution, Trapped Volume and Ability to Maintain a Membrane-Potential. Biochimica Et Biophysica Acta 1985, 812, (1), 55–65.

    CAS  Google Scholar 

  • Hruby, M.; Konak, C.; Ulbrich, K., Polymeric micellar pH-sensitive drug delivery system for doxorubicin. Journal of Controlled Release 2005, 103, (1), 137–148.

    CAS  PubMed  Google Scholar 

  • Hsieh, H. L.; Quirk, R. P., Anionic Polymerization : Principles and Practical Applications. Marcel Dekker: New York, 1996; p 727.

    Google Scholar 

  • Jaeckle, K. A.; Phuphanich, S.; van den Bent, M. J.; Aiken, R.; Batchelor, T.; Campbell, T.; Fulton, D.; Gilbert, M.; Heros, D.; Rogers, L.; O'Day, S. J.; Akerley, W.; Allen, J.; Baldas, S.; Gertler, S. Z.; Greenberg, H. S.; LaFollette, S.; Lesser, G.; Mason, W.; Recht, L.; Wong, E.; Chamberlain, M. C.; Cohn, A.; Glantz, M. J.; Guthell, J. C.; Maria, B.; Moots, P.; New, P.; Russell, C.; Shapiro, W.; Swinnen, L.; Howell, S. B., Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. British Journal of Cancer 2001, 84, (2), 157–163.

    CAS  PubMed  Google Scholar 

  • Jette, K. K.; Law, D.; Schmitt, E. A.; Kwon, G. S., Preparation and drug loading of poly(ethylene glycol)-block-poly(É›-caprolactone) micelles through the evaporation of a cosolvent azeotrope. Pharmaceutical Research 2004, 21, (7), 1184–91.

    CAS  PubMed  Google Scholar 

  • Juliano, R. L.; Stamp, D., Effect of Particle-Size and Charge on Clearance Rates of Liposomes and Liposome Encapsulated Drugs. Biochemical and Biophysical Research Communications 1975, 63, (3), 651–658.

    CAS  PubMed  Google Scholar 

  • Kabanov, A.; Alakhov, V. Y., Micelles of amphiphilic block copolymers as vehicles for drug delivery. In Amphiphilic Block Copolymers: Self-Assembly and Applications, Alexandridis, P.; Lindman, B., Eds. Elsevier Science B.V.: The Netherlands, 2000; pp 347–376.

    Google Scholar 

  • Kabanov, A. V.; Alakhov, V. Y., Pluronic® block copolymers in drug delivery: From micellar nanocontainers to biological response modifiers. Critical Reviews in Therapeutic Drug Carrier Systems 2002, 19, (1), 1–72.

    CAS  PubMed  Google Scholar 

  • Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y., Pluronic (R) block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release 2002, 82, (2–3), 189–212.

    CAS  PubMed  Google Scholar 

  • Kabanov, A. V.; Chekhonin, V. P.; Alakhov, V. Y.; Batrakova, E. V.; Lebedev, A. S.; Melik-Nubarov, N. S.; Arzhakov, S. A.; Levashov, A. V.; Morozov, G. V.; et al., The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting. FEBS Letters 1989, 258, (2), 343–5.

    CAS  PubMed  Google Scholar 

  • Kato, K.; Hamaguchi, T.; Yasui, H.; Okusaka, T.; Ueno, H.; Ikeda, M.; Shirao, K.; Shimada, Y.; Nakahama, H.; Muro, K.; Matsumura, Y., Phase I study of NK105, a paclitaxel-incorporating micellar nanoparticle, in patients with advanced cancer. Journal of Clinical Oncology 2006, 24, (18), 83 s–83 s.

    Google Scholar 

  • Kim, C.; Lee, S. C.; Kwon, I. C.; Chung, H.; Jeong, S. Y., Complexation of poly(2-ethyl-2-oxazoline)-block-poly(É›-caprolactone) micelles with multifunctional carboxylic acids. Macromolecules 2002, 35, (1), 193–200.

    CAS  Google Scholar 

  • Kim, S.; Howell, S. B., Multivesicular Liposomes Containing Cytarabine Entrapped in the Presence of Hydrochloric-Acid for Intracavitary Chemotherapy. Cancer Treatment Reports 1987, 71, (7–8), 705–711.

    CAS  PubMed  Google Scholar 

  • Kim, S. C., Kim, D.W., Shim, Y.H., Bang, J.S., Oh, H.S., Kim, S.W., and Seo, M.H., In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. Journal of Controlled Release 2001, 72, 191–202.

    CAS  PubMed  Google Scholar 

  • Kim, T. Y., Kim, D.W., Chung, J.Y., Shin, S.G., Kim, S.C., Heo, D.S., Kim, N.K., and Bang, Y.J., Phase I and pharmacokinetics study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clinical Cancer Research 2004, 10, 3708–3716.

    CAS  PubMed  Google Scholar 

  • Klibanov, A. L.; Maruyama, K.; Torchilin, V. P.; Huang, L., Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time of Liposomes. Febs Letters 1990, 268, (1), 235–237.

    CAS  PubMed  Google Scholar 

  • Krasnici, S.; Werner, A.; Eichhorn, M. E.; Schmitt-Sody, M.; Pahernik, S. A.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Naujoks, K.; Dellian, M., Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. International Journal of Cancer 2003, 105, (4), 561–567.

    CAS  Google Scholar 

  • Kwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K., Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. Journal of Controlled Release 1994, 29, 17–23.

    CAS  Google Scholar 

  • Kwon, G. S.; Naito, M.; Kataoka, K.; Yokoyama, M.; Sakurai, Y.; Okano, T., Block copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces, B: Biointerfaces 1994, 2, (4), 429–34.

    CAS  Google Scholar 

  • Kwon, G. S.; Okano, T., Polymeric micelles as new drug carriers. Advanced Drug Delivery Reviews 1996, 21, (2), 107–116.

    CAS  Google Scholar 

  • La, S. B., Okano, T., and Kataoka, K., Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl L-aspartate) block copolymer micelles. Journal of Pharmaceutical Sciences 1996, 85, (1), 85–90.

    CAS  PubMed  Google Scholar 

  • Lam, J. S.; Benson, M. C.; O'Donnell, M. A.; Sawczuk, A.; Gavazzi, A.; Wechsler, M. H.; Sawczuk, I. S., Bacillus Calmete-Guerin plus interferon-α2B intravesical therapy maintains an extended treatment plan for superficial bladder cancer with minimal toxicity. Urologic Oncology: Seminars and Original Investigations 2003, 21, (5), 354–360.

    CAS  PubMed  Google Scholar 

  • Lammers, T.; Kuhnlein, R.; Kissel, M.; Subr, V.; Etrych, T.; Pola, R.; Pechar, M.; Ulbrich, K.; Storm, G.; Huber, P.; Peschke, P., Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. Journal of Controlled Release 2005, 110, (1), 103–18.

    CAS  PubMed  Google Scholar 

  • Langer, C. J., CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanes. Clinical Lung Cancer 2004, 6 Suppl 2, S85–8.

    CAS  PubMed  Google Scholar 

  • Lavasanifar, A.; Samuel, J.; Kwon, G. S., Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. Journal of Controlled Release 2001, 77, (1–2), 155–160.

    CAS  PubMed  Google Scholar 

  • Le Garrec, D.; Gori, S.; Luo, L.; Lessard, D.; Smith, D. C.; Yessine, M. A.; Ranger, M.; Leroux, J. C., Poly(N-vinylpyrrolidone)-block-poly(D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. Journal of Controlled Release 2004, 99, (1), 83–101.

    PubMed  Google Scholar 

  • Lee, J.; Cho, E. C.; Cho, K., Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles. Journal of Controlled Release 2004, 94, (2–3), 323–35.

    CAS  PubMed  Google Scholar 

  • Li, Y.; Kwon, G. S., Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharmaceutical Research 2000, 17, (5), 607–11.

    CAS  PubMed  Google Scholar 

  • Lim Soo, P.; Eisenberg, A., Preparation of block copolymer vesicles in solution. Journal of Polymer Science: Part B: Polymer Physics 2004, 42, (6), 923–938.

    Google Scholar 

  • Lim Soo, P.; Lovric, J.; Davidson, P.; Maysinger, D.; Eisenberg, A., Polycaprolactone-block-poly(ethylene oxide) micelles: A nanodelivery system for 17B-estradiol. Molecular Pharmaceutics 2005, 2, (6), 519–527.

    PubMed  Google Scholar 

  • Lim Soo, P.; Luo, L.; Maysinger, D.; Eisenberg, A., Incorporation and Release of Hydrophobic Probes in Biocompatible Polycaprolactone-block-poly(ethylene oxide) Micelles: Implications for Drug Delivery. Langmuir 2002, 18, (25), 9996–10004.

    Google Scholar 

  • Lin, W. J., Lee, W.J., and Lin, C.C., Stability and release performance of a series of pegylated copolymeric micelles. Pharmaceutical Research 2003, 20, (4), 668–673.

    CAS  PubMed  Google Scholar 

  • Liu, J., Xiao, Y., and Allen, C., Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. Journal of Pharmaceutical Sciences 2004, 93, (1), 132–143.

    CAS  PubMed  Google Scholar 

  • Liu, J.; Allen, C., Polymeric Nanocarriers: Delivery Technology for Therapies of the 21st Century. The Drug Delivery Companies Report Autumn/Winter 2003 2003, 25–29.

    Google Scholar 

  • Liu, J.; Lee, H.; Huesca, M.; Young, A.; Allen, C., Liposome formulation of a novel hydrophobic aryl-imidazole compound for anti-cancer therapy. Cancer Chemotherapy and Pharmacology 2006, 58, (3), 306–318.

    CAS  PubMed  Google Scholar 

  • Liu, J.; Zeng, F.; Allen, C., In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. European Journal of Pharmaceutics and Biopharmaceutics 2007, 65, (3), 309–319.

    CAS  PubMed  Google Scholar 

  • Liu, J.; Zeng, F.; Allen, C., Influence of serum protein on polycarbonate-based copolymer micelles as a delivery system for a hydrophobic anti-cancer agent. Journal of Controlled Release 2005, 103, (2), 481–97.

    CAS  PubMed  Google Scholar 

  • Liu, S. Q.; Tong, Y. W.; Yang, Y.-Y., Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b- poly(D,L-lactide-co-glycolide) with varying compositions. Biomaterials 2005, 26, (24), 5064–5074.

    CAS  PubMed  Google Scholar 

  • Lukyanov, A. N.; Torchilin, V. P., Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Advanced Drug Delivery Reviews 2004, 56, (9), 1273–1289.

    CAS  PubMed  Google Scholar 

  • Luppi, B.; Bigucci, F.; Cerchiara, T.; Andrisano, V.; Pucci, V.; Mandrioli, R.; Zecchi, V., Micelles based on polyvinyl alcohol substituted with oleic acid for targeting of lipophilic drugs. Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents 2005, 12, (1), 21–26.

    CAS  Google Scholar 

  • Luppi, B.; Orienti, I.; Bigucci, F.; Cerchiara, T.; Zuccari, G.; Fazzi, S.; Zecchi, V., Poly(vinylalcohol-co-vinyloleate) for the preparation of micelles enhancing retinyl palmitate transcutaneous permeation. Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents 2002, 9, (3), 147–152.

    CAS  Google Scholar 

  • Maeda, H., The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Advances in Enzyme Regulation 2001, 41, 189–207.

    CAS  PubMed  Google Scholar 

  • Maeda, H.; Matsumura, Y., Tumoritropic and lymphotropic principles of macromolecular drugs. Critical Reviews in Therapeutic Drug Carrier Systems 1989, 6, (3), 193–210.

    CAS  PubMed  Google Scholar 

  • Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shitao, K., Okusaka, T., Ueno, H., Ikeda, M., and Watanabe, N., Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. British Journal of Cancer 2004, 91, 1775–1781.

    CAS  PubMed  Google Scholar 

  • Matsumura, Y.; Maeda, H., A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Research 1986, 46, 6387–92.

    CAS  PubMed  Google Scholar 

  • Matsuoka, S.; Murata, M., Membrane permeabilizing activity of amphotericin B is affected by chain length of phosphatidylcholine added as minor constituent. Biochimica Et Biophysica Acta-Biomembranes 2003, 1617, (1–2), 109–115.

    CAS  Google Scholar 

  • Mayhew, E.; Rustum, Y. M.; Szoka, F.; Papahadjopoulos, D., Role of Cholesterol in Enhancing the Anti-Tumor Activity of Cytosine-Arabinoside Entrapped in Liposomes. Cancer Treatment Reports 1979, 63, (11–1), 1923–1928.

    CAS  PubMed  Google Scholar 

  • Medigene AG Website. www.medigene.com/englisch/projekte

  • Meerum Terwogt, J. M.; ten Bokkel Huinink, W. W.; Schellens, J. H.; Schot, M.; Mandjes, I. A.; Zurlo, M. G.; Rocchetti, M.; Rosing, H.; Koopman, F. J.; Beijnen, J. H., Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel. Anticancer Drugs 2001, 12, (4), 315–23.

    CAS  PubMed  Google Scholar 

  • Mizumura, Y.; Matsumura, Y.; Hamaguchi, T.; Nishiyama, N.; Kataoka, K.; Kawaguchi, T.; Hrushesky, W. J.; Moriyasu, F.; Kakizoe, T., Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity. Japanese Journal of Cancer Research 2001, 92, (3), 328–36.

    CAS  PubMed  Google Scholar 

  • Molineux, G., The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®). Current Pharmaceutical Design 2004, 10, (11), 1235–1244.

    CAS  PubMed  Google Scholar 

  • Montaguti, P.; Melloni, E.; Cavalletti, E., Acute intravenous toxicity of dimethyl sulfoxide, polyethylene glycol 400, dimethylformamide, absolute ethanol, and benzyl alcohol in inbred mouse strains. Arzneimittelforschung 1994, 44, (4), 566–70.

    CAS  PubMed  Google Scholar 

  • Moribe, K.; Maruyama, K.; Iwatsuru, M., Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives. International Journal of Pharmaceutics 1999, 188, (2), 193–202.

    CAS  PubMed  Google Scholar 

  • Nah, J.-W.; Jeong, Y.-I.; Cho, C.-S., Clonazepam release from core-shell type nanoparticles composed of poly(B-benzyl L-glutamate) as the hydrophobic part and poly(ethylene oxide) as the hydrophilic part. Journal of Polymer Science, Part B: Polymer Physics 1998, 36, (3), 415–423.

    CAS  Google Scholar 

  • Nakanishi, T.; Fukushima, S.; Okamoto, K.; Suzuki, M.; Matsumura, Y.; Yokoyama, M.; Okano, T.; Sakurai, Y.; Kataoka, K., Development of the polymer micelle carrier system for doxorubicin. Journal of Controlled Release 2001, 74, (1–3), 295–302.

    CAS  PubMed  Google Scholar 

  • Nishiyama, N.; Kataoka, K., Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacology and Therapeutics 2006, 112, (3), 630–648.

    CAS  PubMed  Google Scholar 

  • Okusaka, T.; Matsumura, Y.; Aoki, K., New approaches for pancreatic cancer in Japan. Cancer Chemotherapy and Pharmacology 2004, 54, (SUPPL. 1).

    Google Scholar 

  • Panchagnula, R., Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics 1998, 172, (1–2), 1–15.

    CAS  Google Scholar 

  • Papahadjopoulos, D., Steric Stabilization. In Liposomes – Rational Design, Janoff, A. S., Ed. Marcel Dekker, Inc.: New York, 1999; pp 1–12.

    Google Scholar 

  • Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K. D.; Woodle, M. C.; Lasic, D. D.; Redemann, C.; et al., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proceedings of the National Academy of Sciences of the United States of America 1991, 88, (24), 11460–4.

    CAS  PubMed  Google Scholar 

  • Parveen, S.; Sahoo, S. K., Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs. Clinical Pharmacokinetics 2006, 45, (10), 965–988.

    CAS  PubMed  Google Scholar 

  • Raffy, S.; Teissie, J., Control of lipid membrane stability by cholesterol content. Biophysical Journal 1999, 76, (4), 2072–2080.

    CAS  PubMed  Google Scholar 

  • Ramaswamy, M.; Zhang, X.; Burt, H. M.; Wasan, K. M., Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers. Journal of Pharmaceutical Sciences 1997, 86, (4), 460–4.

    CAS  PubMed  Google Scholar 

  • Reed, K. W.; Yalkowsky, S. H., Lysis of human red blood cells in the presence of various cosolvents. Journal of Parenteral Science and Technology 1985, 39, (2), 64–9.

    CAS  PubMed  Google Scholar 

  • Ringsdorf, H., Structure and Properties of Pharmacologically Active Polymers. Journal of Polymer Science, Polymer Symposia 1975, (51), 135–153.

    Google Scholar 

  • Rowinsky, E. K.; Rizzo, J.; Ochoa, L.; Takimoto, C. H.; Forouzesh, B.; Schwartz, G.; Hammond, L. A.; Patnaik, A.; Kwiatek, J.; Goetz, A.; Denis, L.; McGuire, J.; Tolcher, A. W., A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies. Journal of Clinical Oncology 2003, 21, (1), 148–57.

    CAS  PubMed  Google Scholar 

  • Saetern, A. M.; Flaten, G. E.; Brandl, M., A method to determine the incorporation capacity of camptothecin in liposomes. Aaps Pharmscitech 2004, 5, (3).

    Google Scholar 

  • Samyang Corporation website. www.samyangpharm.com

  • Satchi-Fainaro, R.; Duncan, R.; Barnes, C. M., Polymer therapeutics for cancer: Current status and future challenges. Advances in Polymer Science 2006, 193, (1), 1–65.

    CAS  Google Scholar 

  • Scarpa, A.; Degier, J., Cation Permeability of Liposomes as a Function of Chemical Composition of Lipid Bilayers. Biochimica Et Biophysica Acta 1971, 241, (3), 789–797.

    CAS  PubMed  Google Scholar 

  • Seki, J.; Sonoke, S.; Saheki, A.; Koike, T.; Fukui, H.; Doi, M.; Mayumi, T., Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins. International Journal of Pharmaceutics 2004, 275, (1–2), 239–48.

    CAS  PubMed  Google Scholar 

  • Senior, J. H., Fate and Behavior of Liposomes Invivo - a Review of Controlling Factors. Crc Critical Reviews in Therapeutic Drug Carrier Systems 1987, 3, (2), 123–193.

    CAS  PubMed  Google Scholar 

  • Senior, J.; Crawley, J. C. W.; Gregoriadis, G., Tissue Distribution of Liposomes Exhibiting Long Half-Lives in the Circulation after Intravenous-Injection. Biochimica Et Biophysica Acta 1985, 839, (1), 1–8.

    CAS  PubMed  Google Scholar 

  • Sessa, G.; Weissman, G., Phospholipid Spherules (Liposomes) as a Model for Biological Membranes. Journal of Lipid Research 1968, 9, (3), 310–318.

    CAS  PubMed  Google Scholar 

  • Seymour, L. W.; Duncan, R.; Strohalm, J.; Kopecek, J., Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. Journal of Biomedical Materials Research 1987, 21, (11), 1341–58.

    CAS  PubMed  Google Scholar 

  • Seymour, L. W.; Ferry, D. R.; Anderson, D.; Hesslewood, S.; Julyan, P. J.; Poyner, R.; Doran, J.; Young, A. M.; Burtles, S.; Kerr, D. J., Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. Journal of Clinical Oncology 2002, 20, (6), 1668–76.

    CAS  PubMed  Google Scholar 

  • Shabbits, J. A.; Chiu, G. N.; Mayer, L. D., Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. Journal of Controlled Release 2002, 84, (3), 161–70.

    CAS  PubMed  Google Scholar 

  • Shaffer, S. A.; Baker Lee, C.; Kumar, A.; Singer, J. W., Proteolysis of xyotax by lysosomal cathepsin B; metabolic profiling in tumor cells using LC-MS. European Journal of Cancer 2002, 38, S129–S129.

    Google Scholar 

  • Shen, L.-J.; Shen, W.-C., Drug evaluation: ADI-PEG-20 - A PEGylated arginine deiminase for arginine-auxotrophic cancers. Current Opinion in Molecular Therapeutics 2006, 8, (3), 240–248.

    CAS  PubMed  Google Scholar 

  • Shuai, X.; Ai, H.; Nasongkla, N.; Kim, S.; Gao, J., Micellar carriers based on block copolymers of poly(É›-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. Journal of Controlled Release 2004, 98, (3), 415–426.

    CAS  PubMed  Google Scholar 

  • Simard, P.; Leroux, J.-C.; Allen, C.; Meyer, O., Liposomes for Drug Delivery. In Nanoparticles for Pharmaceutical Applications, Domb, A. J.; Tabata, Y.; Ravi Kumar, M. N. V.; Farber, S., Eds. ASP: Stevenson Ranch, 2007; pp 1–62.

    Google Scholar 

  • Slichenmyer, W. J.; Rowinsky, E. K.; Donehower, R. C.; Kaufmann, S. H., The current status of camptothecin analogues as antitumor agents. Journal of National Cancer Institute 1993, 85, (4), 271–91.

    CAS  Google Scholar 

  • Soepenberg, O.; De Jonge, M. J. A.; Sparreboom, A.; De Bruin, P.; Eskens, F. A. L. M.; De Heus, G.; Wanders, J.; Cheverton, P.; Ducharme, M. P.; Verweij, J., Phase I and pharmacokinetic study of DE-310 in patients with advanced solid tumors. Clinical Cancer Research 2005, 11, (2 I), 703–711.

    CAS  PubMed  Google Scholar 

  • Sparreboom, A.; van Zuylen, L.; Brouwer, E.; Loos, W. J.; de Bruijn, P.; Gelderblom, H.; Pillay, M.; Nooter, K.; Stoter, G.; Verweij, J., Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications. Cancer Research 1999, 59, (7), 1454–7.

    CAS  PubMed  Google Scholar 

  • Strickley, R. G., Solubilizing excipients in oral and injectable formulations. Pharmaceutical Research 2004, 21, (2), 201–30.

    CAS  PubMed  Google Scholar 

  • Strieth, S.; Eichhorn, M. E.; Sauer, B.; Schulze, B.; Teifel, M.; Michaelis, U.; Dellian, M., Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. International Journal of Cancer 2004, 110, (1), 117–124.

    CAS  Google Scholar 

  • Supratek Pharma Inc. website. www.supratek.com

  • Swenson, C. E.; Perkins, W. R.; Roberts, P.; Janoff, A. S., Liposome technology and the development of Myocet (TM) (liposomal doxorubicin citrate). Breast 2001, 10, 1–7.

    Google Scholar 

  • Thiesen, J.; Kramer, I., Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Pharmacy World and Science 1999, 21, (3), 137–141.

    CAS  PubMed  Google Scholar 

  • Thomson, A. H.; Vasey, P. A.; Murray, L. S.; Cassidy, J.; Fraier, D.; Frigerio, E.; Twelves, C., Population pharmacokinetics in phase I drug development: A phase I study of PK1 in patients with solid tumours. British Journal of Cancer 1999, 81, (1), 99–107.

    CAS  PubMed  Google Scholar 

  • Trimaille, T.; Mondon, K.; Gurny, R.; Moller, M., Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides). International Journal of Pharmaceutics 2006, 319, (1–2), 147–154.

    CAS  PubMed  Google Scholar 

  • Uchino, H.; Matsumura, Y.; Negishi, T.; Koizumi, F.; Hayashi, T.; Honda, T.; Nishiyama, N.; Kataoka, K.; Naito, S.; Kakizoe, T., Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats. British Journal of Cancer 2005, 93, (6), 678–687.

    CAS  PubMed  Google Scholar 

  • Vakil, R.; Kwon, G. S., Poly(ethylene glycol)-b-poly(É›-caprolactone) and PEG-phospholipid form stable mixed micelles in aqueous media. Langmuir 2006, 22, (23), 9723–9729.

    CAS  PubMed  Google Scholar 

  • van Zuylen, L.; Verweij, J.; Sparreboom, A., Role of formulation vehicles in taxane pharmacology. Investigational New Drugs 2001, 19, (2), 125–141.

    PubMed  Google Scholar 

  • Vasey, P. A.; Kaye, S. B.; Morrison, R.; Twelves, C.; Wilson, P.; Duncan, R.; Thomson, A. H.; Murray, L. S.; Hilditch, T. E.; Murray, T.; Burtles, S.; Fraier, D.; Frigerio, E.; Cassidy, J., Phase I clinical and pharmacokinetic study of PK1 [N-(2- hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents - Drug-polymer conjugates. Clinical Cancer Research 1999, 5, (1), 83–94.

    CAS  PubMed  Google Scholar 

  • Veronese, F. M.; Pasut, G., PEGylation, successful approach to drug delivery. Nature Reviews Drug Discovery 2005, 10, (21), 1451–8.

    CAS  Google Scholar 

  • Vicent, M. J.; Duncan, R., Polymer conjugates: Nanosized medicines for treating cancer. Trends in Biotechnology 2006, 24, (1), 39–47.

    CAS  PubMed  Google Scholar 

  • Wachters, F. M.; Groen, H. J.; Maring, J. G.; Gietema, J. A.; Porro, M.; Dumez, H.; de Vries, E. G.; van Oosterom, A. T., A phase I study with MAG-camptothecin intravenously administered weekly for 3 weeks in a 4-week cycle in adult patients with solid tumours. British Journal of Cancer 2004, 90, (12), 2261–7.

    CAS  PubMed  Google Scholar 

  • Waterhouse, D. N.; Madden, T. D.; Cullis, P. R.; Bally, M. B.; Mayer, L. D.; Webb, M. S., Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Liposomes, Pt E, 2005; Vol. 391, pp 40–57.

    CAS  Google Scholar 

  • Webb, M. S.; Saxon, D.; Wong, F. M. P.; Lim, H. J.; Wang, Z.; Bally, M. B.; Choi, L. S. L.; Cullis, P. R.; Mayer, L. D., Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): Effects on the pharmacokinetics of liposomal vincristine. Biochimica Et Biophysica Acta-Biomembranes 1998, 1372, (2), 272–282.

    CAS  Google Scholar 

  • Wente, M. N.; Kleeff, J.; Buchler, M. W.; Wanders, J.; Cheverton, P.; Langman, S.; Friess, H., DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors. Investigational New Drugs 2005, 23, (4), 339–347.

    CAS  PubMed  Google Scholar 

  • Wong, H. L.; Bendayan, R.; Rauth, A. M.; Wu, X. Y., Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. Journal of Controlled Release 2006, 116, (3), 275–284.

    CAS  PubMed  Google Scholar 

  • Woodle, M. C.; Lasic, D. D., Sterically Stabilized Liposomes. Biochimica Et Biophysica Acta 1992, 1113, (2), 171–199.

    CAS  PubMed  Google Scholar 

  • Yamamoto, Y.; Nagasaki, Y.; Kato, Y.; Sugiyama, Y.; Kataoka, K., Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge. Journal of Controlled Release 2001, 77, (1–2), 27–38.

    CAS  PubMed  Google Scholar 

  • Yamaoka, T.; Tabata, Y.; Ikada, Y., Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. Journal of Pharmaceutical Sciences 1994, 83, (4), 601–6.

    CAS  PubMed  Google Scholar 

  • Yasugi, K.; Nagasaki, Y.; Kato, M.; Kataoka, K., Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier. Journal of Controlled Release 1999, 62, (1–2), 89–100.

    CAS  PubMed  Google Scholar 

  • Yokoyama, M., Fukushima, S., Uehara, R., Okamoto, K., Kataoka, K., Sakurai, Y., and Okano, T., Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. Journal of Controlled Release 1998, 50, 79–92.

    CAS  PubMed  Google Scholar 

  • Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D. A.; Torchilin, V. P.; Jain, R. K., Vascular-Permeability in a Human Tumor Xenograft - Molecular-Size Dependence and Cutoff Size. Cancer Research 1995, 55, (17), 3752–3756.

    CAS  PubMed  Google Scholar 

  • Zhang, J. A.; Anyarambhatla, G.; Ma, L.; Ugwu, S.; Xuan, T.; Sardone, T.; Ahmad, I., Development and characterization of a novel Cremophor (R) EL free liposome-based paclitaxel (LEP-ETU) formulation. European Journal of Pharmaceutics and Biopharmaceutics 2005, 59, (1), 177–187.

    CAS  PubMed  Google Scholar 

  • Zhang, J. A.; Xuan, T.; Parmar, M.; Ma, L.; Ugwu, S.; Ali, S.; Ahmad, I., Development and characterization of a novel liposome-based formulation of SN-38. International Journal of Pharmaceutics 2004, 270, (1–2), 93–107.

    CAS  PubMed  Google Scholar 

  • Zhigaltsev, I. V.; Maurer, N.; Akhong, Q. F.; Leone, R.; Leng, E.; Wang, J.; Semple, S. C.; Cullis, P. R., Liposome-encapsulated vincristine, vinblastine and vinorelbine: A comparative study of drug loading and retention. Journal of Controlled Release 2005, 104, (1), 103–111.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences, University of Toronto, 144 College St., Toronto, Ontario, Canada M5S 3M2

    Patrick Lim Soo, Michael Dunne, Jubo Liu & Christine Allen

Authors
  1. Patrick Lim Soo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Dunne
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jubo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christine Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Wisconsin, Madison, WI, USA

    Melgardt M. de Villiers  & Glen S. Kwon  & 

  2. Chulalongkorn University, Bangkok, Thailand

    Pornanong Aramwit

Rights and permissions

Reprints and permissions

Copyright information

© 2009 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Soo, P.L., Dunne, M., Liu, J., Allen, C. (2009). Nano-sized Advanced Delivery Systems as Parenteral Formulation Strategies for Hydrophobic Anti-cancer Drugs. In: de Villiers, M.M., Aramwit, P., Kwon, G.S. (eds) Nanotechnology in Drug Delivery. Biotechnology: Pharmaceutical Aspects, vol X. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77668-2_12

Download citation

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation